Literature DB >> 10159516

Balloon angioplasty for postoperative recurrent coarctation of the aorta.

Z M Hijazi1, R L Geggel.   

Abstract

Surgical repair for recurrent or residual postoperative coarctation of the aorta is associated with some morbidity, mortality, and an incidence of recurrent coarctation that may be as high as 20%. Balloon angioplasty for recurrent or residual postoperative coarctation has become the standard treatment of choice for this condition. In this article, we review the protocol we use, and the acute and long-term results of this procedure. Since 1983, over 400 patients have undergone balloon angioplasty for recurrent coarctation with excellent immediate relief of the gradient and improvement in the diameter. On long-term follow-up, the majority of these patients enjoyed a lasting beneficial effect of the balloon angioplasty. We discuss the future use of stents for selected patients who are not amenable or failed balloon angioplasty of recurrent or residual postoperative coarctation.

Entities:  

Mesh:

Year:  1995        PMID: 10159516     DOI: 10.1111/j.1540-8183.1995.tb00579.x

Source DB:  PubMed          Journal:  J Interv Cardiol        ISSN: 0896-4327            Impact factor:   2.279


  3 in total

1.  The adult patient with native coarctation of the aorta: balloon angioplasty or primary stenting?

Authors:  C Zabal; F Attie; M Rosas; A Buendía-Hernández; J A García-Montes
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

2.  Safety and efficacy of low-profile balloons in native coarctation and recoarctation balloon angioplasty for infants.

Authors:  Muhammad Dilawar; Howaida Galal El Said; Amal El-Sisi; Zaheer Ahmad
Journal:  Pediatr Cardiol       Date:  2009-04-14       Impact factor: 1.655

3.  Recoartación de la aorta en pacientes sometidos a angioplastia percutánea con o sin implantación de stent

Authors:  María A Cañas-Galvis; Rafael Lince-Varela; Luis H Díaz-Medina; Rafael Correa; Diana Restrepo
Journal:  Arch Cardiol Mex       Date:  2021
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.